Home > Healthcare > Biotechnology > Biopharma > Circulating Tumor Cells (CTC) Market

Circulating Tumor Cells (CTC) Market Share

Report ID: GMI6095
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Circulating Tumor Cells Market Share

Major market players operating in the circulating tumor cells market include

Thermo Fisher Scientific Inc.
QIAGEN
Precision for Medicine
BIOCEPT, Inc.
Fluxion Biosciences, Inc.
Greiner Bio One International GmbH
Ikonisys Inc.
Miltenyi Biotec
IVDiagnostics
BioFluidica
Biolidics Limited
Creativ MicroTech, Inc.
LungLife AI, Inc.
Rarecells Diagnostics
ScreenCell
Sysmex Corporation
STEMCELL Technologies, Inc.

These industry players majorly adopt various strategies including collaborations, acquisitions, mergers, and partnerships to create a global footprint and sustain market competition.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for circulating tumor cells size was USD 11.1 billion in 2022 and will reach USD 33.5 billion by end of 2032 owing to the rising demand for effective diagnostic and treatment solutions.

Circulating tumor cells industry share from the research application segment recorded USD 8.1 billion in 2022 driven by increasing adoption in cancer research to offer valuable insights into tumor biology and cancer prognosis.

North America held 42.4% of the circulating tumor cells market share in 2022 and is anticipated to expand considerably through 2032 due to the increasing advancements in diagnostic technologies

Thermo Fisher Scientific Inc., QIAGEN, Precision for Medicine, BIOCEPT, Inc., BioFluidica, Fluxion Biosciences, Inc., Greiner Bio One International GmbH, Ikonisys Inc., Miltenyi Biotec, IVDiagnostics, and Biolidics Limited are some prominent firms providing circulating tumor cells.